GRANULESPharmaceuticals
Granules India Ltd — Quarterly Results & Earnings
₹620.40
-0.75%
Profit Growth YoY34.33%Latest quarter
Sales Growth YoY34.18%Latest quarter
Sales CAGR 5Y11.52%5 year compound
Profit CAGR 5Y8.80%5 year compound
📋
Quarterly Performance
YoY Profit Growth+34.33%
🔥 Exceptional growth
YoY Sales Growth+34.18%
🔥 Exceptional growth
OPM 5Y Average
20.99%Operating profit margin
EPS Growth 5Y
9.83%Interest Coverage
7.43Higher = safer debt servicing
ROE
13.86%ROCE
15.14%💡
Growth Analysis
Granules India Ltd reported YoY profit growth of 34.33% and revenue growth of 34.18% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at 11.52% and profits at 8.80% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Granules India Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.